LifeSciences BC Announces Paul V. Drohan as New President & CEO

LifeSciences BC Announces Paul V. Drohan as New President & CEO

VANCOUVER, British Columbia--(BUSINESS WIRE)--LifeSciences BC is pleased to announce the appointment of Paul V. Drohan as its new President & CEO.

"We're delighted that someone of Paul's stature and expertise has come home to help LifeSciences BC realize its global potential"
"I'm excited to be joining LifeSciences BC, a leader in the life sciences industry in B.C. and across Canada," says Paul. "We have an extraordinary biotech and life sciences history here in the Province, and I look forward to building on this history in this dynamic period. We're seeing radical changes in business models, access to capital and technologies like wireless and ICT converging in this space. Within this environment, I want to ensure that the life sciences sector in B.C. is sustainable and attractive provincially, nationally and internationally. By realizing our potential as a global leader in life sciences, LifeSciences BC will help strengthen our stakeholders and the Province."

Paul has over 25 years of experience in the biopharmaceutical industry, and has recently returned from the United Kingdom where he lived and worked for the past eight years. Most recently, Paul was with Genzyme (a Sanofi Company) as Senior Global Vice President, leading the organizations' strategic, financial and sales and marketing operations performance for the U.K., Republic of Ireland, South Africa, Australia, New Zealand and Canada.

For more biographical information, please visit Paul's LinkedIn page:

http://uk.linkedin.com/pub/paul-v-drohan/7/a94/132

"We're delighted that someone of Paul's stature and expertise has come home to help LifeSciences BC realize its global potential," says Gordon McCauley, Chair, LifeSciences BC. "At the same time, we owe a deep debt of gratitude to Don Enns who has served in this role for the last three years. Don's contributions have been extraordinary, and we're delighted that he is staying within our life sciences business community in a leadership role with one of our members."

About LifeSciences BC

LifeSciences BC is a not-for-profit industry association with a mission to build a world-class life sciences community in British Columbia that contributes to the economic and societal wellbeing of the Province through a collaborative effort between industry, academia and government. LifeSciences BC works to broaden the representation of British Columbia's converging "bio" community by building a forum for complementary technologies, and supporting the Province's life sciences industry through advocacy, facilitation and promotion.

Contacts

LifeSciences BC
Jason Lesage, 604-602-5227
Manager, Communications & Public Relations
[email protected]

Suggested Articles

Three years after Bayer and gene-editing biotech CRISPR Therapeutics joined forces to launch and run Casebia Therapeutics.

Fresh off Tilos Therapeutics’ $773 million sale to Merck, Barbara Fox is taking the helm of another Cambridge-based company: Rheos Medicines.

The data tee Seattle Genetics up to file for FDA approval of a TKI inhibitor it paid $614 million to acquire last year.